Aurinia Pharmaceuticals Inc (AUPH) Social Stream

Featured Post From StockTwits About AUPH

$AUPH If there is no BO by the end of September, my guess is that the management and Peter want to see a full A2 data readouts to create more value for shareholders and their stock options.

Neil Solomons “…obviously towards the back half of the year, there is ASN and ACR and its our intention to submit even more data there”.

Beat $40-50M at the end of 2021 + good A2 data ➡️ SoC + new indications from VOC ➡️Create more value for shareholders in 2022!

So, if the above statement is true, I could see BO > $10B+++ in 2022.

Excellent A2 data readouts up to 33 months. We need to see 3 more months of data readouts. If A2 full data readouts is excellent, BO will follow IMMU path during 1H 2022. Gl!